Brainsway vs NeuroPace
BWAY and NPCE side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BWAY and NPCE compare
Brainsway grew revenue faster over the last twelve months (27.3% versus 23.0% for NeuroPace).
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BWAY | NPCE |
|---|---|---|
| Size and price | ||
| Market cap | – | $413M |
| Share price | $11.24 | $12.02 |
| Change, 1 year | 39.5% | −10.9% |
| Change, 5 years | 183% | 1.4% |
| Beta (5Y) | 1.29 | 1.05 |
| Employees | 129 | 209 |
| StockData Score | ||
| Total score | 5 | 5 |
| Valuation score | 0 | 0 |
| Growth score | 4 (better) | 3 |
| Performance score | 0 | 1 (better) |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 3.9× |
| P/B | – | 35.9× |
| FCF yield | – | −3.0% |
| Fair value | – | $6.78 |
| Margin of safety | – | −77.2% |
| Growth | ||
| Revenue growth (TTM) | 27.3% (better) | 23.0% |
| Revenue growth, 5Y average | 18.8% | 19.4% (better) |
| EPS growth (TTM) | 260% | – |
| Profitability | ||
| Gross margin | 75.4% | 77.8% (better) |
| Operating margin | 8.3% (better) | −9.5% |
| Net margin | – | −17.7% |
| FCF margin | – | −11.6% |
| Return on equity | – | −126% |
| Return on invested capital | – | −41.4% |
| Financial health | ||
| Debt / equity | – | 5.15 |
| Interest coverage | 2.0× (better) | −1.6× |
| Current ratio | 3.59 | 5.26 (better) |
| Altman Z-score | – | −3.79 |
| Piotroski F-score | – | 5 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.00% |
| Years of dividend growth | – | 0 |
| Buyback yield | – | 0.00% |
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 29.2% | 77.4% |
| Held by insiders | 25.5% | 16.6% |
| Insider net buying, 12 months | – | −$399K |
| Short interest, % of float | – | 3.0% |
Go deeper
- BWAY stock overview
- BWAY income statement
- BWAY valuation and score
- NPCE stock overview
- NPCE income statement
- NPCE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.